As the Australian market experiences its typical September sell-off, investors are closely watching sectors like energy and healthcare for signs of stability amidst fluctuating gold prices and anticipation of a US Federal Reserve decision. In such volatile times, identifying stocks with strong financials becomes crucial, especially when considering smaller or newer companies that might offer both affordability and growth potential. While the term "penny stocks" may seem outdated, these investments continue to attract attention for their unique opportunities; we'll explore three such stocks that stand out in today's market landscape.

Top 10 Penny Stocks In Australia

Name Share Price Market Cap Financial Health Rating Dusk Group (ASX:DSK) A$0.81 A$50.44M ★★★★★★ IVE Group (ASX:IGL) A$2.60 A$402.03M ★★★★★☆ MotorCycle Holdings (ASX:MTO) A$3.38 A$249.47M ★★★★★★ Pureprofile (ASX:PPL) A$0.042 A$49.13M ★★★★★★ Veris (ASX:VRS) A$0.075 A$38.83M ★★★★★★ West African Resources (ASX:WAF) A$3.04 A$3.47B ★★★★★★ Praemium (ASX:PPS) A$0.765 A$365.83M ★★★★★★ SKS Technologies Group (ASX:SKS) A$3.27 A$374.82M ★★★★★★ Service Stream (ASX:SSM) A$2.38 A$1.46B ★★★★★★ MaxiPARTS (ASX:MXI) A$2.50 A$138.61M ★★★★★★

Click here to see the full list of 440 stocks from our ASX Penny Stocks screener.

Let's review some notable picks from our screened stocks.

Metals X

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Metals X Limited is an Australian company focused on tin production, with a market capitalization of A$571.72 million.

Operations: The company's revenue is primarily derived from its 50% stake in the Renison Tin Operation, amounting to A$271.38 million.

Market Cap: A$571.72M

Metals X Limited has demonstrated significant financial growth, with earnings surging by a very large 708.2% over the past year, surpassing both its historical average and industry benchmarks. The company is debt-free, enhancing its financial stability and flexibility. Its recent half-year results show sales of A$147.54 million and net income of A$52.95 million, reflecting improved profit margins from last year. Despite a large one-off gain impacting recent results, Metals X maintains strong liquidity with short-term assets exceeding liabilities significantly. Trading at a low price-to-earnings ratio of 4.1x suggests it may offer good relative value in the market.

Navigate through the intricacies of Metals X with our comprehensive balance sheet health report here. Review our growth performance report to gain insights into Metals X's future.ASX:MLX Financial Position Analysis as at Sep 2025

Maronan Metals

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Maronan Metals Limited focuses on the exploration, evaluation, and development of mineral resource properties in Australia, with a market cap of A$60.38 million.

Story Continues

Operations: Maronan Metals Limited has not reported any revenue segments.

Market Cap: A$60.38M

Maronan Metals Limited, with a market cap of A$60.38 million, remains pre-revenue and unprofitable, reporting a net loss of A$8.83 million for the year ending June 2025. The company has no long-term liabilities and is debt-free, but it faces financial challenges with less than a year of cash runway based on current free cash flow trends. Recent executive changes include the temporary leave of Managing Director Richard Carlton, with Chairman Simon Bird assuming interim responsibilities to ensure leadership continuity. Despite these hurdles, Maronan's management team and board are experienced, averaging tenures over two years.

Take a closer look at Maronan Metals' potential here in our financial health report. Gain insights into Maronan Metals' historical outcomes by reviewing our past performance report.ASX:MMA Debt to Equity History and Analysis as at Sep 2025

Nanosonics

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Nanosonics Limited is a global infection prevention company with a market cap of A$1.23 billion.

Operations: The company generated A$198.63 million in revenue from its Healthcare Equipment segment.

Market Cap: A$1.23B

Nanosonics Limited, with a market cap of A$1.23 billion, has demonstrated robust earnings growth, increasing by 59.4% over the past year compared to its five-year average of 20.4%. Despite having no debt and stable weekly volatility, its Return on Equity remains low at 9.8%. The company's short-term assets significantly exceed both short-term and long-term liabilities, ensuring financial stability. Recent guidance projects revenue between A$215 million and A$223 million for fiscal year 2026. Dr Lisa McIntyre will step down from the board in November 2025 after contributing significantly as Chair of the Innovation & Development Committee.

Unlock comprehensive insights into our analysis of Nanosonics stock in this financial health report. Learn about Nanosonics' future growth trajectory here.ASX:NAN Debt to Equity History and Analysis as at Sep 2025

Next Steps

Get an in-depth perspective on all 440  ASX Penny Stocks by using our screener here. Ready To Venture Into Other Investment Styles? The end of cancer? These 29 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:MLX ASX:MMA and ASX:NAN.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments